Mylan Specialty (f/k/a Dey)
Mylan operates a fully integrated specialty pharmaceutical business, Mylan Specialty, which is focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, severe allergic reactions and psychiatric disorders.
Mylan Specialty markets a number of innovative medicinal therapies, including the next-generation, needle-protected EpiPen® Auto-Injector, which treats life-threatening allergic reactions (also known as anaphylaxis). EpiPen is the no. 1 prescribed auto-injector with a 90% world market share in the U.S. and worldwide